| Literature DB >> 30574438 |
Davis G Taylor1, Avery L Buchholz2, Durga R Sure3, Thomas J Buell1, James H Nguyen1, Ching-Jen Chen1, Joshua M Diamond1, Perry A Washburn4, James Harrop5, Christopher I Shaffrey1, Justin S Smith1.
Abstract
STUDYEntities:
Keywords: back pain; discitis; osteodiscitis; outcome; pyogenic; spondylodiscitis
Year: 2018 PMID: 30574438 PMCID: PMC6295820 DOI: 10.1177/2192568218799058
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Figure 1.Flowchart outlining the systematic review process. The initial PubMed search resulted in 1286 articles. Subsequent screening and application of inclusion and exclusion criteria yielded 50 total articles to undergo detailed review and pooling of data. Two additional articles were identified after similar process through Cochrane Review.
Summary of the 50 Studies Included in Pooled Data for Presenting Features of Pyogenic Spondylodiscitis.
| Demographics | Presentation | Lesion Location | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| First Author, Year | Paper Type | Patients (n) | Men (n) | Mean Age (Years) | Time to Diagnosis (Days) | Back Pain | Neurological Findings | Cervical | Thoracic | Lumbar |
| Aagaard, 2013 | Retrospective review | 100 | 37 | 60 | 32 | 25 | 26 | 65 | ||
| Asamoto, 2005 | Retrospective review | 21 | 13 | 66 | 19 | 12 | 5 | 7 | 11 | |
| Ascione 2017 | Retrospective review | 30 | 13 | 64 | 28 | 30 | 5 | 0 | 2 | 20 |
| Bernard, 2015 | Randomized controlled trial | 351 | 242 | 61 | 337 | 57 | 52 | 96 | 246 | |
| Bettini, 2009 | Retrospective review | 56 | 21 | 48 | 34 | 56 | 18 | 3 | 8 | 48 |
| Butler, 2006 | Retrospective review | 48 | 24 | 59 | 47 | 14 | 4 | 11 | 30 | |
| Bydone, 2014 | Retrospective review | 118 | 57 | 67 | 61 | 35 | 40 | 43 | ||
| Cebrian, 2012 | Retrospective review | 108 | 49 | 68 | 97 | 27 | 4 | 38 | 66 | |
| Chung, 2011 | Retrospective review | 20 | 13 | 60 | 20 | 14 | 0 | 8 | 12 | |
| Citak, 2014 | Retrospective review | 183 | 99 | 63 | 80 | 14 | 66 | 97 | ||
| D’Agostino, 2010 | Prospective series | 81 | 51 | 58 | 55.4 | 79 | 12 | 10 | 59 | 12 |
| D’Aliberti, 2012 | Retrospective review | 40 | 29 | 56 | 39 | 16 | 13 | 18 | 9 | |
| Dennis, 2017 | Retrospective | 84 | 49 | 62 | 68 | 19 | 29 | 79 | 156 | |
| Eysel, 1997 | Retrospective review | 55 | 28 | 52 | ||||||
| Ha, 2007 | Retrospective review | 24 | 14 | 23 | 7 | 0 | 0 | 24 | ||
| Hadjipavlou, 2000 | Retrospective review | 101 | 76 | 46 | 40 | 10 | 33 | 55 | ||
| Heyde, 2006 | Retrospective review | 20 | 11 | 60 | 84 | 9 | ||||
| Homagk, 2016 | Retrospective review | 270 | 153 | 64 | 101 | 30 | 103 | 149 | ||
| Hopf, 1998 | Retrospective review | 72 | 39 | 52 | 0 | 40 | 49 | |||
| Karadimas, 2008 | Retrospective review | 163 | 101 | 56 | 13 | 72 | 88 | |||
| Kaya, 2014 | Retrospective review | 107 | 64 | 53 | 97 | 18 | 7 | 14 | 90 | |
| Kehrer, 2015 | Retrospective review | 298 | 182 | 66 | 33 | 38 | 95 | 203 | ||
| Klockner, 2003 | Retrospective review | 71 | 38 | 54 | 18 | 0 | 33 | 39 | ||
| Krodel, 1991 | Retrospective review | 24 | 50 | |||||||
| Legrand, 2001 | Retrospective review | 110 | 67 | 61 | 40 | 18 | 3 | 23 | 69 | |
| Lemaignen, 2017 | Retrospective review | 394 | 267 | 63 | 40 | 369 | 130 | 71 | 137 | 281 |
| Lin CP, 2012 | Retrospective review | 48 | 19 | 67 | 144 | 48 | 28 | 0 | 16 | 38 |
| Lin TY, 2014 | Retrospective review | 45 | 25 | 62 | 0 | 9 | 36 | |||
| Lin Y, 2015 | Retrospective review | 22 | 13 | 55 | 22 | 8 | 0 | 0 | 22 | |
| Lu, 2015 | Retrospective review | 28 | 13 | 60 | 6 | 0 | 2 | 28 | ||
| Mann, 2004 | Prospective series | 24 | 14 | 63 | 24 | 13 | 4 | 10 | 10 | |
| Nasto, 2014 | Retrospective review | 27 | 18 | 60 | 33 | 0 | 5 | 22 | ||
| Noh, 2017 | Retrospective review | 31 | 27 | 68 | 18 | 3 | 8 | 20 | ||
| Pee, 2008 | Retrospective review | 60 | 36 | 59 | 58 | 16 | 0 | 0 | 60 | |
| Rath, 1996 | Retrospective review | 43 | 24 | 60 | 46 | 35 | 0 | 19 | 24 | |
| Shinkel, 2003 | Retrospective review | 32 | 18 | 61 | 32 | 17 | 21 | 19 | 35 | |
| Schomacher, 2014 | Retrospective review | 37 | 24 | 62 | 37 | 6 | 6 | 25 | ||
| Shetty, 2016 | Retrospective review | 27 | 19 | 48 | 6 | |||||
| Shiban, 2014 | Retrospective review | 113 | 78 | 104 | 40 | |||||
| Shousha, 2012 | Retrospective review | 30 | 19 | 65 | 24 | 12 | 30 | 0 | 0 | |
| Sobottke, 2009 | Retrospective review | 20 | 14 | 43 | 23 | 3 | 2 | 6 | 12 | |
| Srinivasan, 2014 | Retrospective review | 48 | 29 | 56 | ||||||
| Suess, 2007 | Retrospective review | 24 | 15 | 65 | 9 | 24 | 7 | 3 | 14 | 7 |
| Tsai, 2017 | Retrospective review | 90 | 61 | 61 | ||||||
| Valancius, 2013 | Retrospective review | 196 | 106 | 52.5 | 177 | 47 | 9 | 42 | 125 | |
| Vcelak, 2014 | Retrospective review | 31 | 20 | 61 | 9 | 6 | 25 | |||
| Viale, 2009 | Prospective series | 48 | 36 | 60 | 9 | 6 | 9 | 29 | ||
| Wirtz, 2000 | Retrospective review | 59 | 29 | 61 | 90 | 46 | ||||
| Yaldz, 2015 | Retrospective review | 39 | 19 | 47 | 105 | 37 | 18 | 0 | 15 | 24 |
| Ziu, 2014 | Retrospective review | 102 | 87 | 45 | 102 | 26 | 9 | 24 | 59 | |
| Surgical Treatment | Follow-up | |||||||
|---|---|---|---|---|---|---|---|---|
| First Author, Year | Decompression or Decompression and Fusion | Patients (n) | Duration (Months) | Neurologic Deficits | Return to Work | Pain Free | Oswestry Disability Index <20% | Excellent Functional Outcome |
| Aagaard, 2013 | 94 | 3 | 26 | |||||
| Asamoto, 2005 | 21 | 11 | 11 | |||||
| Ascione, 2017 | 30 | 30 | 8 | 22 | 4 | 22 | ||
| Bernard, 2015 | 283 | 12 | 10 | |||||
| Bettini, 2009 | 3 | 56 | 12 | |||||
| Butler, 2006 | 0 | |||||||
| Bydone, 2014 | 118 | 15 | 23 | |||||
| Cebrian, 2012 | 108 | 6 | 35 | 35 | ||||
| Chung, 2014 | 20 | 20 | 36 | 4 | 20 | 20 | 20 | |
| Citak, 2011 | 102 | 183 | ||||||
| D’Agostino, 2010 | 10 | 72 | 65 | |||||
| D’Aliberti, 2012 | 40 | 40 | 43 | 13 | 17 | 17 | ||
| Eysel, 1997 | 55 | 42 | ||||||
| Ha, 2007 | 1 | |||||||
| Hadjipavlou, 2000 | 62 | 47 | 14 | |||||
| Heyde, 2006 | 37 | 3 | ||||||
| Homagk, 2016 | ||||||||
| Hopf, 1998 | 72 | 38 | 1 | |||||
| Karadimas, 2008 | 93 | 163 | 12 | 22 | ||||
| Kaya, 2014 | 94 | 94 | ||||||
| Klockner, 2003 | 71 | 71 | 64 | |||||
| Krodel, 1991 | 36 | |||||||
| Legrand, 2001 | 99 | 3 | 42 | 42 | ||||
| Lemaignen, 2017 | 58 | 378 | 5 | 26 | ||||
| Lin CP, 2012 | 48 | 48 | 64 | 32 | 32 | 32 | ||
| Lin TY, 2014 | 45 | 45 | 24 | |||||
| Lin Y, 2015 | 22 | 22 | 31 | 0 | 19 | 19 | ||
| Lu, 2015 | 28 | 28 | 20 | 0 | 10 | 15 | 25 | |
| Mann, 2004 | 24 | 15 | 15 | |||||
| Nasto, 2014 | 12 | 27 | 9 | |||||
| Pee, 2008 | 60 | 60 | 36 | 5 | ||||
| Rath, 1996 | 45 | 41 | 15 | |||||
| Shinkel, 2003 | 32 | 20 | 49 | 10 | ||||
| Schomacher, 2014 | 37 | 37 | 20 | |||||
| Shiban, 2014 | 106 | 3 | 16 | |||||
| Shousha, 2012 | 30 | 27 | 28 | |||||
| Sobottke, 2009 | 11 | 13 | ||||||
| Srinivasan, 2014 | 48 | |||||||
| Suess, 2007 | 24 | 24 | 18 | |||||
| Tsai, 2017 | 43 | |||||||
| Valancius, 2013 | 117 | 80 | 12 | 64 | 64 | |||
| Vcelak, 2014 | 31 | 30 | 12 | 27 | 27 | |||
| Wirtz, 2000 | 59 | 26 | ||||||
| Yaldz, 2015 | 12 | 39 | 96 | 1 | ||||
| Ziu, 2014 | 24 | 66 | 7 | |||||
| Demographic and Clinical Data (n = Number of Studies) | |||
|---|---|---|---|
| No. of patients (n = 50) | 4173 | ||
| Percent men (n = 48) | 60 | ||
| Age (years) (n = 46) | 58.28 | ||
| Time to diagnosis (days) (n = 16) | 54.93 | ||
| Length of follow-up (months) (n = 33) | 26.14 | ||
| Comorbidities | Number | Total | Percent |
| Concurrent infection (n = 14) | 207 | 834 | 35 |
| Cardiovascular disease (n = 13) | 260 | 1083 | 24 |
| Intravenous drug abuse (n = 14) | 226 | 1379 | 15 |
| Diabetes (n = 33) | 651 | 3727 | 20 |
| Immunosuppression (n = 20) | 274 | 2429 | 11 |
| End-stage renal disease (n = 17) | 111 | 1263 | 9 |
| Back pain on presentation (n = 28) | 2101 | 2299 | 91 |
| Fever on presentation (n = 21) | 748 | 2125 | 35 |
| Neurologic deficits on presentation (n = 38) | 1009 | 3422 | 29 |
| Laboratory and Diagnostic Data (n = Number of Studies) | Number | Total | Percent |
|---|---|---|---|
| Imaging | |||
| MRI positive (n = 14) | 980 | 1045 | 94 |
| Bone scan positive (n = 1) | 14 | 15 | 93 |
| CT positive (n = 4) | 127 | 146 | 87 |
| X-ray positive (n = 4) | 129 | 185 | 70 |
| Levels involved | |||
| Cervical (n = 40) | 459 | 3824 | 12 |
| Thoracic (n = 42) | 1219 | 3919 | 31 |
| Lumbar (n = 42) | 2863 | 3943 | 62 |
| Associated abscess (n = 18) | 567 | 1924 | 29 |
| Labs | |||
| Elevated CRP (>10 mg/L) (n = 16) | 1083 | 1272 | 85 |
| Elevated ESR (>20 mm/h) (n = 12) | 464 | 672 | 69 |
| Leukocytosis (n = 16) | 457 | 1052 | 43 |
| Culture yield | |||
| Surgical biopsy positive (n = 13) | 296 | 511 | 58 |
| Percutaneous biopsy positive (n = 8) | 149 | 261 | 57 |
| Blood culture positive (n = 13) | 475 | 930 | 51 |
| Negative cultures (n = 27) | 447 | 1583 | 28 |
| Culture results | |||
| | 1268 | 3360 | 38 |
| | 126 | 866 | 15 |
| Gram-negative rods (n = 28) | 214 | 1810 | 12 |
| Streptococcus (n = 26) | 181 | 1472 | 12 |
| Enterococcus (n = 22) | 55 | 913 | 6 |
Abbreviations: CRP, C-reactive protein; CT, computed tomography; ESR, erythrocyte sedimentation rate; MRI, magnetic resonance imaging.
Surgical Procedures Performed Among Surgical Reports.
| Surgery Demographics (n = Number of Studies) | Number | Total | Percent |
|---|---|---|---|
| Decompression and fusion among surgical patients (n = 27) | 1049 | 1321 | 79 |
| Treated surgically (n = 46) | 2133 | 3384 | 63 |
| Decompression alone among surgical patients (n = 22) | 223 | 1024 | 22 |
| Anterior and posterior combined approach (n = 22) | 448 | 1364 | 33 |
| Staged surgery (n = 13) | 128 | 485 | 26 |
| Reoperation rate (n = 24) | 119 | 891 | 13 |
Figure 2.Forest plot of the odds ratios (ORs) of pain free outcomes among surgical and medical cohorts with infectious spondylodiscitis. The estimated OR and 95% confidence interval (CI) of each included study are represented by the center of the squares and the horizontal line, respectively. The summary OR and 95% CI are represented by the diamond. Heterogeneity and overall effect are given below the summary statistics.
Figure 3.Forest plot of the mean difference in visual analog score among surgical and medical cohorts with infectious spondylodiscitis. The estimated mean difference and 95% confidence interval (CI) of each included study are represented by the center of the squares and the horizontal line, respectively. The summary mean difference and 95% CI are represented by the diamond. Heterogeneity and overall effect are given below the summary statistics.